vs
Side-by-side financial comparison of GRIFFON CORP (GFF) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
GRIFFON CORP is the larger business by last-quarter revenue ($649.1M vs $493.8M, roughly 1.3× Pediatrix Medical Group, Inc.). GRIFFON CORP runs the higher net margin — 9.9% vs 6.8%, a 3.1% gap on every dollar of revenue. On growth, GRIFFON CORP posted the faster year-over-year revenue change (2.6% vs -1.7%). Over the past eight quarters, Pediatrix Medical Group, Inc.'s revenue compounded faster (-0.1% CAGR vs -1.8%).
Griffon Corporation is a multinational conglomerate headquartered in New York City. It operates as a diversified management and holding company. The company has four subsidiaries: Ames True Temper, ClosetMaid, Clopay Building Products, and CornellCookson. Griffon has been publicly traded since 1961 and is listed on the New York Stock Exchange as a component stock of the S&P SmallCap 600, S&P Composite 1500, and Russell 2000 indices.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
GFF vs MD — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $649.1M | $493.8M |
| Net Profit | $64.4M | $33.7M |
| Gross Margin | 41.1% | — |
| Operating Margin | 17.5% | 9.9% |
| Net Margin | 9.9% | 6.8% |
| Revenue YoY | 2.6% | -1.7% |
| Net Profit YoY | -9.1% | 10.5% |
| EPS (diluted) | $1.41 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $649.1M | $493.8M | ||
| Q3 25 | $662.2M | $492.9M | ||
| Q2 25 | $613.6M | $468.8M | ||
| Q1 25 | $611.7M | $458.4M | ||
| Q4 24 | $632.4M | $502.4M | ||
| Q3 24 | $659.7M | $511.2M | ||
| Q2 24 | $647.8M | $504.3M | ||
| Q1 24 | $672.9M | $495.1M |
| Q4 25 | $64.4M | $33.7M | ||
| Q3 25 | $43.6M | $71.7M | ||
| Q2 25 | $-120.1M | $39.3M | ||
| Q1 25 | $56.8M | $20.7M | ||
| Q4 24 | $70.9M | $30.5M | ||
| Q3 24 | $62.5M | $19.4M | ||
| Q2 24 | $41.1M | $-153.0M | ||
| Q1 24 | $64.1M | $4.0M |
| Q4 25 | 41.1% | — | ||
| Q3 25 | 41.7% | — | ||
| Q2 25 | 43.2% | — | ||
| Q1 25 | 41.2% | — | ||
| Q4 24 | 41.8% | — | ||
| Q3 24 | 39.9% | — | ||
| Q2 24 | 38.5% | — | ||
| Q1 24 | 40.2% | — |
| Q4 25 | 17.5% | 9.9% | ||
| Q3 25 | 18.0% | 13.8% | ||
| Q2 25 | -20.5% | 12.8% | ||
| Q1 25 | 16.5% | 7.0% | ||
| Q4 24 | 17.7% | 7.8% | ||
| Q3 24 | 16.9% | 6.6% | ||
| Q2 24 | 13.8% | -31.3% | ||
| Q1 24 | 16.9% | 3.2% |
| Q4 25 | 9.9% | 6.8% | ||
| Q3 25 | 6.6% | 14.5% | ||
| Q2 25 | -19.6% | 8.4% | ||
| Q1 25 | 9.3% | 4.5% | ||
| Q4 24 | 11.2% | 6.1% | ||
| Q3 24 | 9.5% | 3.8% | ||
| Q2 24 | 6.3% | -30.3% | ||
| Q1 24 | 9.5% | 0.8% |
| Q4 25 | $1.41 | $0.40 | ||
| Q3 25 | $1.04 | $0.84 | ||
| Q2 25 | $-2.65 | $0.46 | ||
| Q1 25 | $1.21 | $0.24 | ||
| Q4 24 | $1.49 | $0.37 | ||
| Q3 24 | $1.29 | $0.23 | ||
| Q2 24 | $0.84 | $-1.84 | ||
| Q1 24 | $1.28 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $95.3M | $375.2M |
| Total DebtLower is stronger | — | $570.5M |
| Stockholders' EquityBook value | $108.9M | $865.9M |
| Total Assets | $2.1B | $2.2B |
| Debt / EquityLower = less leverage | — | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $95.3M | $375.2M | ||
| Q3 25 | $99.0M | $340.1M | ||
| Q2 25 | $107.3M | $224.7M | ||
| Q1 25 | $127.8M | $99.0M | ||
| Q4 24 | $152.0M | $229.9M | ||
| Q3 24 | $114.4M | $103.8M | ||
| Q2 24 | $133.5M | $19.4M | ||
| Q1 24 | $123.0M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | — | $577.2M | ||
| Q2 25 | $1.5B | $583.9M | ||
| Q1 25 | $1.5B | $590.5M | ||
| Q4 24 | $1.5B | $597.1M | ||
| Q3 24 | $1.5B | — | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.6B | — |
| Q4 25 | $108.9M | $865.9M | ||
| Q3 25 | $74.0M | $890.7M | ||
| Q2 25 | $63.9M | $833.8M | ||
| Q1 25 | $214.7M | $789.2M | ||
| Q4 24 | $227.8M | $764.9M | ||
| Q3 24 | $224.9M | $732.5M | ||
| Q2 24 | $223.5M | $706.5M | ||
| Q1 24 | $202.2M | $856.2M |
| Q4 25 | $2.1B | $2.2B | ||
| Q3 25 | $2.1B | $2.2B | ||
| Q2 25 | $2.1B | $2.1B | ||
| Q1 25 | $2.3B | $2.0B | ||
| Q4 24 | $2.3B | $2.2B | ||
| Q3 24 | $2.4B | $2.1B | ||
| Q2 24 | $2.4B | $2.0B | ||
| Q1 24 | $2.4B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.65× | ||
| Q2 25 | 22.71× | 0.70× | ||
| Q1 25 | 7.16× | 0.75× | ||
| Q4 24 | 6.48× | 0.78× | ||
| Q3 24 | 6.78× | — | ||
| Q2 24 | 6.74× | — | ||
| Q1 24 | 7.84× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $107.0M | $114.1M |
| Free Cash FlowOCF − Capex | $99.3M | — |
| FCF MarginFCF / Revenue | 15.3% | — |
| Capex IntensityCapex / Revenue | 1.2% | — |
| Cash ConversionOCF / Net Profit | 1.66× | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | $278.9M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $107.0M | $114.1M | ||
| Q3 25 | $75.0M | $137.3M | ||
| Q2 25 | $123.1M | $137.2M | ||
| Q1 25 | $16.5M | $-117.5M | ||
| Q4 24 | $142.9M | $133.0M | ||
| Q3 24 | $72.1M | $91.8M | ||
| Q2 24 | $122.1M | $107.0M | ||
| Q1 24 | $39.8M | $-125.2M |
| Q4 25 | $99.3M | — | ||
| Q3 25 | $62.4M | — | ||
| Q2 25 | $114.4M | — | ||
| Q1 25 | $2.8M | — | ||
| Q4 24 | $125.5M | — | ||
| Q3 24 | $51.6M | — | ||
| Q2 24 | $107.5M | — | ||
| Q1 24 | $20.8M | — |
| Q4 25 | 15.3% | — | ||
| Q3 25 | 9.4% | — | ||
| Q2 25 | 18.6% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 19.8% | — | ||
| Q3 24 | 7.8% | — | ||
| Q2 24 | 16.6% | — | ||
| Q1 24 | 3.1% | — |
| Q4 25 | 1.2% | — | ||
| Q3 25 | 1.9% | — | ||
| Q2 25 | 1.4% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 2.8% | — | ||
| Q3 24 | 3.1% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 2.8% | — |
| Q4 25 | 1.66× | 3.39× | ||
| Q3 25 | 1.72× | 1.91× | ||
| Q2 25 | — | 3.49× | ||
| Q1 25 | 0.29× | -5.66× | ||
| Q4 24 | 2.02× | 4.36× | ||
| Q3 24 | 1.15× | 4.72× | ||
| Q2 24 | 2.97× | — | ||
| Q1 24 | 0.62× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GFF
| Consumer And Professional Products | $241.1M | 37% |
| Residential Repairand Remodel | $202.1M | 31% |
| International Excluding North America | $97.8M | 15% |
| Retail | $47.3M | 7% |
| Residential New Construction | $32.5M | 5% |
| Other | $14.2M | 2% |
| Industrial | $14.1M | 2% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
